2021 annual financial data

United Therapeutics Corporation - Common Stock 2021 Net margin

United Therapeutics Corporation - Common Stock 2021 net margin with verified re…

Direct answer

Net margin was 28.23%.

Operating income was 555,900,000 USD and net income was 475,800,000 USD.
Operating cash flow was 598,200,000 USD.
Alpha Vantage

Verified data

Revenue
1,685,500,000 USD
Operating income
555,900,000 USD
Net income
475,800,000 USD
Operating cash flow
598,200,000 USD

Explore related company data

View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all United Therapeutics Corporation - Common Stock financial years